Herbert J. Zeh, III MD, FACS
1 clinical trials · Sponsor
◉ Watch Herbert J. Zeh, III MD, FACS
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer (NCT00336700) | Herbert J. Zeh, III MD, FACS | 2006-06-01 |
Track Herbert J. Zeh, III MD, FACS automatically
Every clearance here is in the API, with alerts when new ones post.